10x Genomics
TXG
Performance
About 10x Genomics
10x Genomics develops and sells advanced genomic analysis technologies that enable researchers to analyze biological samples at high resolution. Their products focus on single-cell sequencing and spatial transcriptomics to reveal cellular composition, interactions, and gene expression within tissues. They serve life sciences institutions globally, supporting cancer, immunology, neuroscience, and developmental biology research to advance human health. Headquartered in the United States, they provide instruments, reagents, and datasets to accelerate discoveries across research labs and clinical studies.
Recent News
Advancing Single-Cell Transcriptomics Into the Mainstream of Biomedical Research
Swedish CubaseBio Emerges From Stealth with €5.9 Million to Scale Volumetric DNA Microscopy
Ex-CEO Behind Bars, 10x’s Clinical Ambitions, Pharma’s AI Gambit
Building Intelligent Workflows for the Multiomic Era
Tahoe, Arc Institute, and Biohub Join Forces on Massive Virtual Cell Dataset
Two Years on From Its Launch, How Has the UPC Impacted European Patent Litigation in the Life Sciences Sector?
Weekly TechBio News
GCs See Merits of Data-Driven Outside Counsel Selection but Also Its Limitations
Recent Deals
No recent deals for this company.
